
Metformin and Long COVID, Central Lines and Thrombocytopenia, DOACs vs LMWH in Cancer Associated Thrombosis, Early vs Late Anticoagulation after Stroke with Atrial Fibrillation
Last Week in Medicine
00:00
Metformin for Long COVID and Misinterpretation of Data
The potential use of metformin in treating long COVID is discussed, weighing its safe profile and affordability against the need for more study replication. Ongoing studies evaluating other medications for long COVID are mentioned, along with a discussion on the misinterpretation of data regarding treatment effectiveness in vaccinated individuals.
Play episode from 16:42
Transcript


